Evidence map›Paper›PMID 33050005›Full record

ArticleInternational journal of molecular sciences2020

Intraarticular Administration Effect of Hydrogen Sulfide on an In Vivo Rat Model of Osteoarthritis.

Carlos Vaamonde-García, Elena F Burguera, Ángela Vela-Anero, Tamara Hermida-Gómez, Purificación Filgueira-Fernández, Jennifer A Fernández-Rodríguez, Rosa Meijide-Faílde, Francisco J Blanco

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Carlos Vaamonde-GarcíaGrupo de Terapia Celular y Medicina Regenerativa, Universidad de A Coruña, Agrupación Estratégica CICA- INIBIC, Complexo Hospitalario Universitario A Coruña, Campus Oza, 15006 A Coruña, Spain.ORCID 0000-0001-8658-5502
Elena F BurgueraGrupo de Investigación en Reumatología (GIR), INIBIC-Complexo Hospitalario Universitario A Coruña, Sergas, As Xubias, 15006 A Coruña, Spain.
Ángela Vela-AneroGrupo de Terapia Celular y Medicina Regenerativa, Universidad de A Coruña, Agrupación Estratégica CICA- INIBIC, Complexo Hospitalario Universitario A Coruña, Campus Oza, 15006 A Coruña, Spain.
Tamara Hermida-GómezGrupo de Investigación en Reumatología (GIR), INIBIC-Complexo Hospitalario Universitario A Coruña, Sergas, As Xubias, 15006 A Coruña, Spain.
Purificación Filgueira-FernándezGrupo de Investigación en Reumatología (GIR), INIBIC-Complexo Hospitalario Universitario A Coruña, Sergas, As Xubias, 15006 A Coruña, Spain.
Jennifer A Fernández-RodríguezGrupo de Envejecimiento e Inflamación, Agrupación Estratégica CICA- INIBIC, Complexo Hospitalario Universitario A Coruña, Sergas, Universidad de A Coruña, As Xubias, 15006 A Coruña, Spain.
Rosa Meijide-FaíldeGrupo de Terapia Celular y Medicina Regenerativa, Universidad de A Coruña, Agrupación Estratégica CICA- INIBIC, Complexo Hospitalario Universitario A Coruña, Campus Oza, 15006 A Coruña, Spain.ORCID 0000-0001-8516-9419
Francisco J BlancoGrupo de Investigación en Reumatología (GIR), INIBIC-Complexo Hospitalario Universitario A Coruña, Sergas, As Xubias, 15006 A Coruña, Spain.ORCID 0000-0001-9821-7635
Complexo Hospitalario Universitario A Coruña · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESUniversidade da Coruña · ES

Funding

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia ED481D2017/023Fondos de Investigación Sanitaria PI16/02124 and RIERXunta de Galicia AGRUP2015/05 CICA-INIBICXunta de Galicia IN607A 2017/11(GPC)
6 · The paper itself

Abstract

Osteoarthritis (OA) is the most common articular chronic disease. However, its current treatment is limited and mostly symptomatic. Hydrogen sulfide (H

Indexed as

AnimalsArthralgiaCartilage, ArticularCyclooxygenase 2Disease Models, AnimalFemaleGene Expression RegulationHydrogen SulfideInjections, Intra-ArticularMatrix Metalloproteinase 13MorpholinesMotor ActivityNF-E2-Related Factor 2Nitric Oxide Synthase Type IIOrganothiophosphorus CompoundsOsteoarthritisCyclooxygenase 2GYY 4137Hydrogen SulfideMatrix Metalloproteinase 13Mmp13 protein, ratMorpholinesNfe2l2 protein, ratNF-E2-Related Factor 2Nitric Oxide Synthase Type IINos2 protein, ratOrganothiophosphorus CompoundsProtective AgentsPtgs2 protein, rathydrogen sulfideinflammationNrf-2osteoarthritisoxidative damage

Identifiers

PMID33050005
PMCPMC7582513
OpenAlexW3092603901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.